Chemoinformaics analysis of Carvacrol methyl ether
| Molecular Weight | 164.248 | nRot | 2 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 6 |
| Exact Molecular Weight | 164.12 | nRing | 1 |
| Solubility: LogS | -4.249 | nHRing | 0 |
| Solubility: LogP | 3.979 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 29.8407 |
| nHD | 0 | BPOL | 17.7873 |
| QED | 0.652 |
| Synth | 1.546 |
| Natural Product Likeliness | -0.339 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.042 |
| Pgp-sub | 0.066 |
| HIA | 0.006 |
| CACO-2 | -4.462 |
| MDCK | 0.0000209 |
| BBB | 0.823 |
| PPB | 0.950995 |
| VDSS | 2.77 |
| FU | 0.0540872 |
| CYP1A2-inh | 0.95 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.804 |
| CYP2c19-sub | 0.91 |
| CYP2c9-inh | 0.513 |
| CYP2c9-sub | 0.8 |
| CYP2d6-inh | 0.601 |
| CYP2d6-sub | 0.91 |
| CYP3a4-inh | 0.252 |
| CYP3a4-sub | 0.603 |
| CL | 8.666 |
| T12 | 0.343 |
| hERG | 0.026 |
| Ames | 0.029 |
| ROA | 0.049 |
| SkinSen | 0.133 |
| Carcinogencity | 0.358 |
| EI | 0.989 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.787482 |